Unraveling the cell-type-specific molecular pathways of PTSD: integrating GWAS with brain genomic profiling and in vitro modeling
Neuropsychopharmacology
.
2024 Jan;49(1):303-304.
doi: 10.1038/s41386-023-01698-x.
Authors
Artemis Iatrou
1
2
3
,
Nikolaos P Daskalakis
4
5
6
Affiliations
1
McLean Hospital, Belmont, MA, USA.
2
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
3
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
4
McLean Hospital, Belmont, MA, USA. ndaskalakis@mclean.harvard.edu.
5
Department of Psychiatry, Harvard Medical School, Boston, MA, USA. ndaskalakis@mclean.harvard.edu.
6
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. ndaskalakis@mclean.harvard.edu.
PMID:
37580460
PMCID:
PMC10700486
(available on
2025-01-01
)
DOI:
10.1038/s41386-023-01698-x
No abstract available
Publication types
News
MeSH terms
Brain / metabolism
Genetic Predisposition to Disease
Genome-Wide Association Study
Genomics
Humans
Stress Disorders, Post-Traumatic* / genetics
Stress Disorders, Post-Traumatic* / metabolism
Grants and funding
P50 MH115874/MH/NIMH NIH HHS/United States
R01 MH106595/MH/NIMH NIH HHS/United States
R01 MH117292/MH/NIMH NIH HHS/United States
R21 MH121909/MH/NIMH NIH HHS/United States